{"acquisitions":[],"changes":[],"country":"US","description":"Aktis Oncology develops targeted alpha-emitter radiopharmaceuticals using a proprietary miniprotein radioconjugate platform. It serves cancer patients with tumor types previously out of reach of radioligand therapies. Differentiator: miniprotein scaffolds aim to expand the radiopharmaceutical-treatable patient population.","domain":"aktisoncology.com","employees":null,"founded":2020,"fundingTotalQuarantined":false,"githubOrg":"twbs","githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":42.358834,"lng":-71.05783,"location":"Boston MA","multiples":[],"name":"Aktis Oncology","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":175000000,"connectionsAmong":[],"currency":"USD","date":"2024-09-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"aktisoncology-com-2024-09-01-series-b","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-05","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"aktisoncology-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-05","status":"attributed","url":null},{"fact":"existence","publisher":"aktisoncology.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://aktisoncology.com"},{"fact":"description","publisher":"aktisoncology.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://aktisoncology.com"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Nginx","WordPress","MailChimp for WordPress 4.12.5","Yoast SEO 27.6","Genesis theme","Google Analytics","Google Tag Manager","Sassy Social Share 3.3.79","PHP","DoubleClick Floodlight","Contact Form 7 6.1.6","WP Engine"],"totalRaisedUsd":175000000,"traction":[],"updatedAt":"2026-05-05","valuations":[]}